ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $980,000 | +2.4% | 7,230 | -3.3% | 0.07% | -1.4% |
| Q4 2020 | $957,000 | -10.4% | 7,478 | -21.2% | 0.07% | -32.7% |
| Q3 2020 | $1,068,000 | +8.9% | 9,495 | -7.8% | 0.10% | +19.5% |
| Q2 2020 | $981,000 | +30.6% | 10,300 | +23.2% | 0.09% | +67.3% |
| Q1 2020 | $751,000 | -4.1% | 8,359 | -53.5% | 0.05% | +205.9% |
| Q4 2018 | $783,000 | -60.6% | 17,988 | -48.3% | 0.02% | -48.5% |
| Q3 2018 | $1,989,000 | +69.0% | 34,760 | +43.2% | 0.03% | +73.7% |
| Q2 2018 | $1,177,000 | +51.3% | 24,266 | -20.4% | 0.02% | +58.3% |
| Q4 2016 | $778,000 | – | 30,481 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |